UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 19, 2017

Accession Number:
Submission Type:
CIK: 0001444192 Company Name: Acasti Pharma Inc. File Number: 333-220755